Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present China Health Industries Holdings, Inc. (OTC: CHHE).

Full DD Report for CHHE

You must become a subscriber to view this report.


Recent News from (OTC: CHHE)

Wholly-Owned Subsidiary of China Health Industries Holdings, Inc. Signed an OEM Contract
HARBIN, CHINA / ACCESSWIRE / April 19, 2016 / Harbin Humankind Biology Technology Co., Limited ("Humankind"), the wholly-owned subsidiary of China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company"), signed a long-term OEM contract with Yantai Baobei Biote...
Source: ACCESSWIRE IA
Date: April, 19 2016 08:08
China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule
Harbin, China--(Newsfile Corp. - April 4, 2016) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company") today announced that the company has achieved a major technological breakthrough on its original product: Propolis and Black Ant Capsule. China ...
Source: Newsfile
Date: April, 04 2016 06:00
China Health Industries Holdings Announces Third Fiscal Quarter Results
China Health Industries Holdings Announces Third Fiscal Quarter Results
Source: OTC Markets
Date: May, 15 2015 00:00

 


About China Health Industries Holdings, Inc. (OTC: CHHE)

Logo for China Health Industries Holdings, Inc. (OTC: CHHE)

The Company, through different subsidiaries, has the license to manufacture and sell health supplement products and another products. In addition, the Company, through its wholly owned subsidiaries, holds one patent for utility models, five patents for external design, and trademarks in China. The Company is licensed to sell its products, including its medical drugs, only in the PRC.

 

Contact Information

 

 

Current Management

  • Xin Sun / CFO, Treasurer
    • Mr. Xin Sun attended Jia Mu Si Medical College with a major in Pharmacy from to . From to , he was the Production Manager at Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the District Director for the Northeast District of China for Pfizer Pharmaceuticals Limited. Thereafter, he spent one year as the Director of Marketing for Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the Chief Executive Officer of a company he founded, Heilongjiang Bijie Chemical Industry Co., Ltd., which is no longer in existence now. He obtained his Masters of Business Administration from Renmin University of China in . From to the present, he has been the President and Chief Executive Officer of Humankind. Mr. Sun is also President and General Manager of Huimeijia. As a result of his professional experience, Mr. Xin Sun is well known in the pharmaceutical field in Harbin, PRC. While he was studying at Renmin University, Mr. Xin Sun developed many contacts in the pharmaceutical field, many of which later became district agents and other employees in Humankind s distribution system.
  • Baosen Ma / President, Secretary
  • Elizabeth Fei Chen / Counsel
  • Michelle Arbour / Counsel
  • Xin Sun / Chairman
    • Mr. Xin Sun attended Jia Mu Si Medical College with a major in Pharmacy from to . From to , he was the Production Manager at Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the District Director for the Northeast District of China for Pfizer Pharmaceuticals Limited. Thereafter, he spent one year as the Director of Marketing for Ha Yao Group Sanchine Medicine JointStock Company Ltd. From to , he was the Chief Executive Officer of a company he founded, Heilongjiang Bijie Chemical Industry Co., Ltd., which is no longer in existence now. He obtained his Masters of Business Administration from Renmin University of China in . From to the present, he has been the President and Chief Executive Officer of Humankind. Mr. Sun is also President and General Manager of Huimeijia. As a result of his professional experience, Mr. Xin Sun is well known in the pharmaceutical field in Harbin, PRC. While he was studying at Renmin University, Mr. Xin Sun developed many contacts in the pharmaceutical field, many of which later became district agents and other employees in Humankind s distribution system.
  • Baosen Ma /
  • Kai Sun /

Current Share Structure

  • Market Cap: $26,215,895 - 03/16/2018
  • Authorized: 300,000,000 - 06/30/2017
  • Issue and Outstanding: 65,539,737 - 09/12/2017
  • Float: 6,304,556 - 12/30/2016

 


Recent Filings from (OTC: CHHE)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: November, 13 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: September, 27 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 17 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2016
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: November, 07 2016

 

 


Daily Technical Chart for (OTC: CHHE)

Daily Technical Chart for (OTC: CHHE)


Stay tuned for daily updates and more on (OTC: CHHE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CHHE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHHE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CHHE and does not buy, sell, or trade any shares of CHHE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/